FDA Approval and Access Strategy for Lenacapavi...

By Rene Pretorius

June 20, 2025

Summary The FDA has approved Yeztugo (lenacapavir), a revolutionary twice-yearly injection that redefines ...
NICE Rejects Donanemab: Treatment Cost-Effectiveness
Efficacy of Ultomiris Pediatric TMA Treatment
How Gene-Editing Therapies Are Revolutionizing ASCVD Treatment and Market Tra...
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
NICE Approves Transformative Multiple Myeloma Treatment
KEYTRUDA Head Neck Cancer Approval: Transforming Treatment and Health Economics
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
What are the Plans and Implications for Keytruda´s Biosimilar
Blinatumomab Benefit Assessment for ALL and Health Economics
Enhertu Reimbursement Analysis: Navigating Cost-Effectiveness Challenges